Life Sciences & Biotechnology
Title : | Deciphering the role of phosphatidylinoitol 3-kinase
oncogenic mutation in conferring anti HER2 therapy resistance by enriching for the stem-like tumor initiating cell population in HER2 oncogene-positive
breast cancer |
Area of research : | Life Sciences & Biotechnology |
Focus area : | HER2 oncogene-positive breast cancer |
Principal Investigator : | Dr. Anindia Chakrabarty, Shiv Nadar Foundation, Noida |
Timeline Start Year : | 2014 |
Timeline End Year : | 2019 |
Details
Executive Summary : | The project aims to decipher the role of phosphatidylinoitol 3-kinase oncogenic mutation in conferring anti HER2 therapy resistance by enriching for the stem-like tumor initiating cell population in HER2 oncogene-positive breast cancer. |
Organizations involved